Cases With Traumatic and Non Traumatic Brain Damage Treated in the Intensive Care

NCT ID: NCT02475226

Last Updated: 2015-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

135 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-04-30

Study Completion Date

2015-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cases of traumatic and nontraumatic brain damage have high rates of morbidity and mortality. In this study of cases being treated in the ICU for a diagnosis of brain damage, it was aimed to evaluate the relationship between mortality and the distribution of reason for and resulting type of brain damage and to determine other factors affecting mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After local ethics committee approval, a total of 1004 patients treated in the ICU in a 2-year period were retrospectively reviewed. 135 patients, determined with traumatic or nontraumatic brain damage, with a more than 24-hour stay in the ICU, included the study. Reasons for brain damage were determined as brain damage associated with pure head trauma (Group HT), head trauma accompanying general body trauma (Group HT+GBT) and spontaneous haemorrhage (Group SH). The type of brain damage was defined from the radiological diagnosis as subarachnoid haemorrhage, intracranial haemorrhage (ICH), subdural haematoma(SDH), epidural haematoma(EDH), skull fracture, brain contusion or a combination of these (COM).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with body and head trauma

type of the brain injury in patients with brain damage associated both general body and head trauma

type of the brain injury

Intervention Type OTHER

epidural hematoma

type of the brain injury

Intervention Type OTHER

subdural hematoma

type of the brain injury

Intervention Type OTHER

subarachnoid hematoma

type of the brain injury

Intervention Type OTHER

intraparenchymal hematoma

type of the brain injury

Intervention Type OTHER

scull fracture

type of the brain injury

Intervention Type OTHER

brain contusion

Patients with pure head trauma

type of the brain injury in patients with brain damage associated pure head trauma

type of the brain injury

Intervention Type OTHER

epidural hematoma

type of the brain injury

Intervention Type OTHER

subdural hematoma

type of the brain injury

Intervention Type OTHER

subarachnoid hematoma

type of the brain injury

Intervention Type OTHER

intraparenchymal hematoma

type of the brain injury

Intervention Type OTHER

scull fracture

type of the brain injury

Intervention Type OTHER

brain contusion

Patients with spontaneous hemorrhage

type of the brain injury in Patients with brain damage associated spontaneous hemorrhage

type of the brain injury

Intervention Type OTHER

epidural hematoma

type of the brain injury

Intervention Type OTHER

subdural hematoma

type of the brain injury

Intervention Type OTHER

subarachnoid hematoma

type of the brain injury

Intervention Type OTHER

intraparenchymal hematoma

type of the brain injury

Intervention Type OTHER

scull fracture

type of the brain injury

Intervention Type OTHER

brain contusion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

type of the brain injury

epidural hematoma

Intervention Type OTHER

type of the brain injury

subdural hematoma

Intervention Type OTHER

type of the brain injury

subarachnoid hematoma

Intervention Type OTHER

type of the brain injury

intraparenchymal hematoma

Intervention Type OTHER

type of the brain injury

scull fracture

Intervention Type OTHER

type of the brain injury

brain contusion

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients treated in the ICU with the diagnose of traumatic or nontraumatic brain damage, with a more than 24-hour stay.

Exclusion Criteria

* Patients admitted less than 24 hour.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Umraniye Education and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gulsah Karaoren

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nurten Bakan, MD

Role: STUDY_CHAIR

Umraniye Education and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul Umraniye Education and Research Hospital

Istanbul, Turkey, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Sacco S, Marini C, Toni D, Olivieri L, Carolei A. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke. 2009 Feb;40(2):394-9. doi: 10.1161/STROKEAHA.108.523209. Epub 2008 Nov 26.

Reference Type RESULT
PMID: 19038914 (View on PubMed)

Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000 Jan 25;54(2):354-61. doi: 10.1212/wnl.54.2.354.

Reference Type RESULT
PMID: 10668696 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GK7

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Family Involvement in ICU
NCT06770751 RECRUITING